Efavirenz
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65862-105 -
Package NDC
65862-105-10 -
Package NDC
65862-105-30 -
Application number
ANDA078064 -
SPL ID
a02dd4c8-6159-48b0-a79c-c362f1f4daf9 -
SPL set ID
4c57ad7f-321a-46c8-851a-c895466eb8e1 -
UNII
JE6H2O27P8 -
RxCUI
205290 -
RxCUI
205291 -
RxCUI
205292
What the source publishes
- Labeler
- Aurobindo Pharma Limited
- Active ingredients
- Efavirenz
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Efavirenz",
"splId": "a02dd4c8-6159-48b0-a79c-c362f1f4daf9",
"labels": [
{
"setId": "4c57ad7f-321a-46c8-851a-c895466eb8e1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c57ad7f-321a-46c8-851a-c895466eb8e1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c57ad7f-321a-46c8-851a-c895466eb8e1"
}
],
"routes": [
"ORAL"
],
"labeler": "Aurobindo Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (65862-105-10) / 10 CAPSULE in 1 BLISTER PACK",
"package_ndc": "65862-105-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20171215"
},
{
"sample": false,
"description": "30 CAPSULE in 1 BOTTLE (65862-105-30)",
"package_ndc": "65862-105-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20171215"
}
],
"productId": "65862-105_a02dd4c8-6159-48b0-a79c-c362f1f4daf9",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "65862-105",
"deaSchedule": null,
"genericName": "Efavirenz",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "EFAVIRENZ",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA078064",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171215",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175463",
"N0000175460",
"N0000009948",
"N0000190118",
"N0000187064",
"N0000185504",
"N0000182140",
"N0000182141"
],
"unii": [
"JE6H2O27P8"
],
"rxcui": [
"205290",
"205291",
"205292"
],
"spl_set_id": [
"4c57ad7f-321a-46c8-851a-c895466eb8e1"
],
"pharm_class_epc": [
"Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
"Cytochrome P450 3A Inducers [MoA]",
"Cytochrome P450 2B6 Inducers [MoA]",
"Cytochrome P450 2C9 Inhibitors [MoA]",
"Cytochrome P450 2C19 Inhibitors [MoA]",
"Cytochrome P450 3A4 Inhibitors [MoA]"
],
"manufacturer_name": [
"Aurobindo Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65862-105_a02dd4c8-6159-48b0-a79c-c362f1f4daf9"